California Public Employees Retirement System’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.5M Buy
349,929
+67,969
+24% +$9.93M 0.04% 301
2026
Q1
$27.4M Sell
281,960
-9,046
-3% -$913K 0.02% 521
2025
Q4
$23.2M Buy
291,006
+60,032
+26% +$3.94M 0.01% 587
2025
Q3
$10.8M Buy
230,974
+16,544
+8% +$648K 0.01% 875
2025
Q2
$7.89M Buy
214,430
+1,515
+0.7% +$58.2K 0.01% 946
2025
Q1
$7.53M Sell
212,915
-55,374
-21% -$2.25M 0.01% 935
2024
Q4
$11.7M Buy
268,289
+39,475
+17% +$1.99M 0.01% 806
2024
Q3
$10.4M Buy
+228,814
New +$9.96M 0.01% 888
2021
Q2
– Sell
-75,902
Closed -$3.48M – 2663
2021
Q1
$3.48M Sell
75,902
-7,240
-9% -$325K ﹤0.01% 1652
2020
Q4
$3.29M Buy
83,142
+3,042
+4% +$120K ﹤0.01% 1684
2020
Q3
$2.79M Buy
80,100
+47,655
+147% +$1.32M ﹤0.01% 1632
2020
Q2
$1.02M Buy
+32,445
New +$1.02M ﹤0.01% 2227

Other funds holding RVMD

California Public Employees Retirement System's RVMD Position: Q2 2026 in Review

California Public Employees Retirement System increased its Revolution Medicines (RVMD) stake by 24% in Q2 2026, buying an estimated $9.93M and bringing the position to 349,929 shares worth $65.5M. The position accounts for 0.04% of the portfolio, ranked #301.

California Public Employees Retirement System first reported a position in RVMD in Q2 2020 and has held it in 12 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • California Public Employees Retirement System held 349,929 shares of Revolution Medicines worth $65.5M as of Q2 2026.
  • California Public Employees Retirement System bought 67,969 Revolution Medicines shares in Q2 2026, an estimated $9.93M.
  • Revolution Medicines made up 0.04% of California Public Employees Retirement System's portfolio in Q2 2026, its #301 holding.
  • California Public Employees Retirement System first reported a position in Revolution Medicines in Q2 2020 and has held it in 12 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on California Public Employees Retirement System's 13F filing for Q2 2026, filed 14 Aug 2026.